secwatch.observer — SEC 8-K summary
======================================

Issuer:     AVENUE THERAPEUTICS, INC. (ATXI)
CIK:        0001644963
Form:       8-K
Filed at:   2024-05-23T23:59:59+00:00
Accession:  0001437749-24-018072
Event type: regulatory
Sentiment:  positive
Materiality: 0.60
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Avenue Therapeutics regains Nasdaq compliance on equity rule; remains under Panel Monitor until May 2025
--------------------------------------------------------------------------------

- Notified by Nasdaq on May 21, 2024, that it meets minimum stockholders' equity requirement for continued listing.
- Previously disclosed listing matter is now closed.
- Subject to a Panel Monitor for one year (through May 21, 2025).
- If equity rule is not satisfied during monitoring, loses compliance plan option and must request a hearing.
- Company trades as ATXI on Nasdaq Capital Market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1644963/000143774924018072/0001437749-24-018072-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1644963/000143774924018072/atxi20240522_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-018072

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer